H-1B sponsorship profile: Kenox Pharmaceuticals Inc. Across U.S. Department of Labor LCA disclosures, Kenox Pharmaceuticals Inc filed 5 Labor Condition Applications covering 5 H-1B worker positions between fiscal year 2024 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (5 certified of 5 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Kenox Pharmaceuticals Inc’s H-1B petitions range from $81,120 at the low end to $95,000 at the high end, with a petition-weighted average of $90,224. That range reflects the mix of occupations the company sponsors, led by SCIENTIST I (4 petitions at $92,500 avg), followed by DIRECTOR OF PRODUCT DEVELOPMENT. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Kenox Pharmaceuticals Inc is headquartered in MONMOUTH JUNCTION, NJ under NAICS code 325412, and places H-1B workers across 1 state, most heavily in NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Kenox Pharmaceuticals Inc ranks. By H-1B petition volume, Kenox Pharmaceuticals Inc is #26,547 of 119,880 employers nationally and #1,935 of 5,818 employers headquartered in NJ. Both ranks are computed live from the same underlying petition counts, not a separate estimate.